Blueprint Medicines Reports Second Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Blueprint Medicines Reports Second Quarter 2021 Financial Results

Blueprint Medicines (BPMC) Reports In-Line Q2 EPS

July 29, 2021 7:42 AM EDT

Blueprint Medicines (NASDAQ: BPMC) reported Q2 EPS of ($1.86), in-line with the analyst estimate of ($1.86). Revenue for the quarter came in at $27.3 million versus the consensus estimate of $19.01 million.

For earnings history and earnings-related data on Blueprint Medicines (BPMC) click here.

... More